Cargando…
Meningioma Cell Invasion into DuraGen-Derived Dura Mater: A Case Report
Background: Dura mater infiltration is the main growth pattern of meningiomas. Local recurrence may occur in any type of meningioma, but it is more likely so in atypical meningiomas. Therefore, a wide resection of tumor cell-invaded dura mater is necessary to avoid recurrence. DuraGen(®) (an artific...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024904/ https://www.ncbi.nlm.nih.gov/pubmed/35447878 http://dx.doi.org/10.3390/medicines9040030 |
_version_ | 1784690727453720576 |
---|---|
author | Tamura, Ryota Kuranari, Yuki Orikasa, Hideki Katayama, Makoto |
author_facet | Tamura, Ryota Kuranari, Yuki Orikasa, Hideki Katayama, Makoto |
author_sort | Tamura, Ryota |
collection | PubMed |
description | Background: Dura mater infiltration is the main growth pattern of meningiomas. Local recurrence may occur in any type of meningioma, but it is more likely so in atypical meningiomas. Therefore, a wide resection of tumor cell-invaded dura mater is necessary to avoid recurrence. DuraGen(®) (an artificial dural substitute) can be used for dural reconstruction in meningiomas. Here, we report a rare case of a patient with atypical meningioma that invaded into the DuraGen(®)-derived mature dura mater. Case presentation: A 66-year-old female showed a three-time recurrence of atypical meningioma. Simpson grade I resection (en bloc tumor with autologous dura mater and DuraGen(®)-derived dura mater resection) was achieved at the 3rd recurrence. Collagen fibers running regularly and transversely were observed in the DuraGen(®)-derived dura mater resembling the autologous meningeal layer. Meningioma cell invasion, displayed by occasional EMA immunostaining, was observed in the DuraGen(®)-derived dura mater. Conclusions: This case indicates that meningioma cells may invade and survive in the DuraGen(®-)derived dura mater. Whether or not DuraGen(®) is not appropriate as a dural substitute remains unanswered. Further experiences are needed to validate these findings in large sample sizes. |
format | Online Article Text |
id | pubmed-9024904 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90249042022-04-23 Meningioma Cell Invasion into DuraGen-Derived Dura Mater: A Case Report Tamura, Ryota Kuranari, Yuki Orikasa, Hideki Katayama, Makoto Medicines (Basel) Case Report Background: Dura mater infiltration is the main growth pattern of meningiomas. Local recurrence may occur in any type of meningioma, but it is more likely so in atypical meningiomas. Therefore, a wide resection of tumor cell-invaded dura mater is necessary to avoid recurrence. DuraGen(®) (an artificial dural substitute) can be used for dural reconstruction in meningiomas. Here, we report a rare case of a patient with atypical meningioma that invaded into the DuraGen(®)-derived mature dura mater. Case presentation: A 66-year-old female showed a three-time recurrence of atypical meningioma. Simpson grade I resection (en bloc tumor with autologous dura mater and DuraGen(®)-derived dura mater resection) was achieved at the 3rd recurrence. Collagen fibers running regularly and transversely were observed in the DuraGen(®)-derived dura mater resembling the autologous meningeal layer. Meningioma cell invasion, displayed by occasional EMA immunostaining, was observed in the DuraGen(®)-derived dura mater. Conclusions: This case indicates that meningioma cells may invade and survive in the DuraGen(®-)derived dura mater. Whether or not DuraGen(®) is not appropriate as a dural substitute remains unanswered. Further experiences are needed to validate these findings in large sample sizes. MDPI 2022-04-11 /pmc/articles/PMC9024904/ /pubmed/35447878 http://dx.doi.org/10.3390/medicines9040030 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Tamura, Ryota Kuranari, Yuki Orikasa, Hideki Katayama, Makoto Meningioma Cell Invasion into DuraGen-Derived Dura Mater: A Case Report |
title | Meningioma Cell Invasion into DuraGen-Derived Dura Mater: A Case Report |
title_full | Meningioma Cell Invasion into DuraGen-Derived Dura Mater: A Case Report |
title_fullStr | Meningioma Cell Invasion into DuraGen-Derived Dura Mater: A Case Report |
title_full_unstemmed | Meningioma Cell Invasion into DuraGen-Derived Dura Mater: A Case Report |
title_short | Meningioma Cell Invasion into DuraGen-Derived Dura Mater: A Case Report |
title_sort | meningioma cell invasion into duragen-derived dura mater: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024904/ https://www.ncbi.nlm.nih.gov/pubmed/35447878 http://dx.doi.org/10.3390/medicines9040030 |
work_keys_str_mv | AT tamuraryota meningiomacellinvasionintoduragenderivedduramateracasereport AT kuranariyuki meningiomacellinvasionintoduragenderivedduramateracasereport AT orikasahideki meningiomacellinvasionintoduragenderivedduramateracasereport AT katayamamakoto meningiomacellinvasionintoduragenderivedduramateracasereport |